| Typicality: | 0.436 |
| Saliency: | 0.342 |
| in patients with dravet syndrome | 6 | other |
| often | 3 | temporal |
| so most of the time | 2 | temporal |
| drug → be compared to → placebo | 22 |
| drug → be compared with → placebo | 17 |
| negative | neutral | positive |
| 0.239 | 0.517 | 0.244 |
| Raw frequency | 39 |
| Normalized frequency | 0.342 |
| Modifier score | 0.625 |
| Perplexity | 54.334 |